SCHEMBL7760593

SCHEMBL7760593

CN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(CO)CO

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AR P10275 18/20 0.72
HDAC1 Q13547 4/20 0.57
PGR P06401 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7759190 0.90 AR (0.74) ARHDAC1
SCHEMBL8939551 0.90 AR (0.74) ARHDAC1
SCHEMBL7759696 0.89 AR (0.67) ARPGR
SCHEMBL7756025 0.87 AR (0.60) ARHDAC1PGR
SCHEMBL7759173 0.84 AR (0.63) ARHDAC1
SCHEMBL30291858 0.84 AR (1.00) ARHDAC1
SCHEMBL1435262 0.84 AR (1.00) ARHDAC1
SCHEMBL8939558 0.83 AR (0.77) ARHDAC1PGR
SCHEMBL8177485 0.81 AR (0.59) ARPGR
SCHEMBL30291848 0.81 AR (0.77) ARHDAC1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0738263-B1 SUBSTITUTED PHENYLIMIDAZOLIDINES HAVING ANTIANDROGEN ACTIVITY AVENTIS PHARMA SA (FR) 2001-04-04 EP disclosed
US-5750553-A ANTIANDROGENIC AGENTS ROUSSEL UCLAF (FR) 1998-05-12 US disclosed